Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: A Phase I Study of HRS-5765 in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 study of HRS-5765 in healthy participants is planned, with Heart Failure listed as the condition; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HRS-5765

Snippet

Sponsor: Chengdu Suncadia Medicine Co., Ltd. | Conditions: Heart Failure | Phase 1 | Status: NOT_YET_RECRUITING